It will face a lot of competition for its treatment of a tricky disease.

BING NEWS:
  • EASL 2024: Hepatocyte journey across liver disease and beyond
    The ongoing European Association for the Study of the Liver 2024 congress in Milan opened yesterday with several presentations on cell plasticity and its role in liver function and regeneration in ...
    06/7/2024 - 4:29 am | View Link
  • Boehringer Weight-Loss Challenger Hits Goals in Liver Study
    A next-generation compound from Boehringer Ingelheim GmbH and Zealand Pharma A/S hit a range of goals in a study of obesity-linked liver disease, in an early sign of how competitive the drug might be ...
    06/6/2024 - 9:56 pm | View Link
  • Lung Cancer Drug’s 'Off-the-Charts’ Results Give Patients Hope
    Researchers believe the drug could make certain kinds of lung cancers a chronic disease like diabetes, and not necessarily a death sentence.
    06/6/2024 - 6:51 am | View Link
  • Zealand Pharma says drug shows improvement in fatty liver disease patients
    Denmark's Zealand Pharma said on Thursday its experimental weight-loss drug showed an improvement in patients with a type of fatty liver disease after results from a mid-stage study were leaked, ...
    06/6/2024 - 1:04 am | View Link
  • Eli Lilly details NASH effects of weight loss drug
    Developers of drugs targeting a liver disease called nonalcoholic steatohepatitis (NASH) trended lower in the premarket on Wednesday after detailed data from a mid-stage trial for Eli Lilly's ...
    06/5/2024 - 1:10 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News